Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas J Schwartzentruber

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Seminars in Oncology Nursing|September 10, 2003
Cancer vaccinesPaula M Muehlbauer, Douglas J Schwartzentruber
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2004
Gastrointestinal perforations associated with interleukin-2 administrationDavid M Heimann, Douglas J Schwartzentruber
Journal of Pediatric Surgery|June 22, 2002
Principles for the surgical management of patients with Proteus syndrome and patients with overgrowth not meeting Proteus criteriaMatthew Lublin, Douglas J Schwartzentruber, Jeff Lukish, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 2, 2002
Safety and efficacy of high-dose interleukin-2 therapy in patients with brain metastasesLisa M Guirguis, James C Yang, Donald E White, et al.
Journal for Immunotherapy of Cancer|September 25, 2019
High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014Janice P Dutcher, Douglas J Schwartzentruber, Howard L Kaufman, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|May 4, 2006
Cardiac magnetic resonance appearance of myocarditis caused by high dose IL-2: similarities to community-acquired myocarditisW Patricia Ingkanisorn, D Ian Paterson, Katherine R Calvo, et al.
The New England Journal of Medicine|August 2, 2003
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancerJames C Yang, Leah Haworth, Richard M Sherry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651Allen M Goorin, Douglas J Schwartzentruber, Meenakshi Devidas, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2003
Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanomaSteven A Rosenberg, James C Yang, Paul F Robbins, et al.
Annals of Surgery|March 8, 2002
Hepatic abscess in patients with chronic granulomatous diseaseMatthew Lublin, David L Bartlett, David N Danforth, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Seminars in Oncology Nursing|September 10, 2003
Cancer vaccinesPaula M Muehlbauer, Douglas J Schwartzentruber
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2004
Gastrointestinal perforations associated with interleukin-2 administrationDavid M Heimann, Douglas J Schwartzentruber
Journal of Pediatric Surgery|June 22, 2002
Principles for the surgical management of patients with Proteus syndrome and patients with overgrowth not meeting Proteus criteriaMatthew Lublin, Douglas J Schwartzentruber, Jeff Lukish, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 2, 2002
Safety and efficacy of high-dose interleukin-2 therapy in patients with brain metastasesLisa M Guirguis, James C Yang, Donald E White, et al.
Journal for Immunotherapy of Cancer|September 25, 2019
High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014Janice P Dutcher, Douglas J Schwartzentruber, Howard L Kaufman, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|May 4, 2006
Cardiac magnetic resonance appearance of myocarditis caused by high dose IL-2: similarities to community-acquired myocarditisW Patricia Ingkanisorn, D Ian Paterson, Katherine R Calvo, et al.
The New England Journal of Medicine|August 2, 2003
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancerJames C Yang, Leah Haworth, Richard M Sherry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651Allen M Goorin, Douglas J Schwartzentruber, Meenakshi Devidas, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2003
Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanomaSteven A Rosenberg, James C Yang, Paul F Robbins, et al.
Annals of Surgery|March 8, 2002
Hepatic abscess in patients with chronic granulomatous diseaseMatthew Lublin, David L Bartlett, David N Danforth, et al.
Pageof 3